We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Jonathan S. Kahan

Washington, D.C.

Jonathan S. Kahan

With more than 40 years of legal experience, Jonathan Kahan is an industry leader in obtaining FDA market clearance of novel medical devices for medical technology and diagnostics companies. He also advises on post-market compliance matters.

Jonathan helps clients navigate complicated regulatory processes, including those related to combination products such as combinations of devices, drugs, biologics, and human tissues. He authored the leading text on medical device law, Medical Device Development: Regulation and Law; (Parexel 2014).

Jonathan is co-director of the firm's Medical Device Practice Group and an adjunct professor who teaches medical device law at the George Washington University Law School. He is also the general counsel of the Association of Medical Diagnostics Manufacturers.

Jonathan is highly ranked by Chambers as well as all other rating services, and has been consistently included in Washington, D.C. Super Lawyers and Washingtonian Magazine's Top Lawyers in D.C.

Representative experience

Assisted client in obtaining premarket approval (PMA) for a novel medical device to treat brain cancer.

Assisted client in obtaining a Humanitarian Device Exemption approval for a novel device that brings sight to patients blinded by retinitis pigmentosa.

Represented a medical device client in resolving a civil money penalty proceeding brought by the FDA.

Assisted client in obtaining de novo reclassification for a novel pill camera for imaging lesions in the colon.

Assisted client in obtaining 510(k) clearance for multiple proton beam therapy systems.

Assisted client in obtaining PMA for a novel gastric balloon system for the treatment of obesity.

Assisted client in the filing of a Request for Designation with the FDA OCP and obtaining a favorable device jurisdictional ruling.

Advised client regarding whether clinical decision software was regulated by the FDA as a medical device.

Education and admissions


  • J.D., with honors, Order of the Coif, The George Washington University Law School, 1973
  • B.A., with honors, The George Washington University, 1970


  • Contributing Editor, Medical Device & Diagnostic Industry Magazine (MD&DI)
  • General Counsel, Association of Medical Diagnostics Manufacturers
  • Member, American Bar Association
  • Member, Editorial Advisory Board, MD&DI 

Bar admissions and qualifications

  • District of Columbia

Court admissions

  • U.S. Court of Appeals, District of Columbia Circuit
  • U.S. District Court, District of Columbia
  • U.S. Supreme Court


Healthcare: Pharmaceutical/Medical Products Regulatory (District of Columbia)

Chambers USA


Life Sciences: Regulatory/Compliance (Nationwide), Recognised Practitioner

Chambers USA


Food and Drugs

Washington, D.C. Super Lawyers



Best Lawyers in America


Most Highly Regarded Firms for Life Sciences

Who's Who Legal

2009-2011, 2013


Washington, D.C. Super Lawyers


Washington's Top Lawyers: Food and Drug



Handbook, Recommended Specialist in 'Life Sciences: Regulatory'

PLC Which Lawyer?


Regulatory Star

LMG Life Sciences


Regulatory: Medical Devices

PLC Life Sciences Cross-border Handbook


Leading Lawyer in Regulatory: Medical Devices

PLC Life Sciences Cross-border Handbook


Medical Device & Diagnostic Industry, Hundred Notables of the Medical Device Industry

Loading data